Request a copy

Full Text

1

CITATION

1 Total citation

0 Recent citations

0.07 Field Citation Ratio

0.02 Relative Citation Ratio

publications

0

supporting

0

mentioning

0

contrasting

0

Smart Citations

0

0

0

0

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.

• Agrawal B., Krantz M.J., Parker J., and Longenecker B.M. Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation. Cancer Res. 58 (1998) 4079-4081
• Ahn S.M., Yoon H.Y., Lee B.G., Park K.C., Chung J.H., Moon C.H., and Lee S.H. Fructose-1,6-diphosphate attenuates prostaglandin E2 production and cyclo-oxygenase-2 expression in UVB-irradiated HaCaT keratinocytes. Br. J. Pharmacol. 137 (2002) 497-503
• Brugger W., Buhring H.J., Grunebach F., Vogel W., Kaul S., Muller R., Brummendorf T.H., Ziegler B.L., Rappold I., Brossart P., Scheding S., and Kanz L. Expression of MUC-1 epitopes on normal bone marrow: implications for the detection of micrometastatic tumor cells. J. Clin. Oncol. 17 (1999) 1535-1544
• Cloosen S., Gratama J.W., van Leeuwen E.B.M., Senden-Gijsbers B.L.M.G., Oving E.B.H., von Mensdorff-Pouilly S., Tarp M.A., Mandel U., Clausen H., Germeraad W.T.V., and Bos G.M.J. Cancer specific Mucin-1 glycoforms are expressed on multiple myeloma. Br. J. Haematol. 135 (2006) 513-516
• Cloosen S., Thio M., Vanclee A., van Leeuwen E.B.M., Senden-Gijsbers B.L.M.G., Oving E.B.H., Germeraad W.T.V., and Bos G.M.J. Mucin-1 is expressed on dendritic cells, both in vitro and in vivo. Int. Immunol. 16 (2004) 1561-1571
• Correa I., Plunkett T., Vlad A., Mungul A., Candelora-Kettel J., Burchell J.M., Taylor-Papadimitriou J., and Finn O.J. Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration. Immunology 108 (2003) 32-41
• Fujita Y., Abe R., Sasaki M., Honda A., Furuichi M., Asano Y., Norisugi O., Shimizu T., and Shimizu H. Presence of circulating CCR10+ T cells and elevated serum CTACK/CCL27 in the early stage of mycosis fungoides. Clin. Cancer Res. 12 (2006) 2670-2675
• Ho S.B., Niehans G.A., Lyftogt C., Yan P.S., Cherwitz D.L., Gum E.T., Dahiya R., and Kim Y.S. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res. 53 (1993) 641-651
• Hollingsworth M.A., and Swanson B.J. Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 4 (2004) 45-60
• Hubert P., Caberg J.H., Gilles C., Bousarghin L., Franzen-Detrooz E., Boniver J., and Delvenne P. E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions. J. Pathol. 206 (2005) 346-355
• Hubert P., van den B.F., Giannini S.L., Franzen-Detrooz E., Boniver J., and Delvenne P. Colonization of in vitro-formed cervical human papillomavirus-associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor. Am. J. Pathol. 154 (1999) 775-784
• Kam J.L., Regimbald L.H., Hilgers J.H., Hoffman P., Krantz M.J., Longenecker B.M., and Hugh J.C. MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats. Cancer Res. 58 (1998) 5577-5581
• Kanda N., Koike S., and Watanabe S. IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes. J. Allergy Clin. Immunol. 116 (2005) 1144-1150
• Kohlgraf K.G., Gawron A.J., Higashi M., Meza J.L., Burdick M.D., Kitajima S., Kelly D.L., Caffrey T.C., and Hollingsworth M.A. Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line. Cancer Res. 63 (2003) 5011-5020
• Legler D.F., Krause P., Scandella E., Singer E., and Groettrup M. Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J. Immunol. 176 (2006) 966-973
• Martin-Fontecha A., Sebastiani S., Hopken U.E., Uguccioni M., Lipp M., Lanzavecchia A., and Sallusto F. Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 198 (2003) 615-621
• Pivarcsi A., and Homey B. Chemokine networks in atopic dermatitis: traffic signals of disease. Curr. Allergy Asthma Rep. 5 (2005) 284-290
• Rahn J.J., Chow J.W., Horne G.J., Mah B.K., Emerman J.T., Hoffman P., and Hugh J.C. MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1. Clin. Exp. Metastasis 22 (2005) 475-483
• Regimbald L.H., Pilarski L.M., Longenecker B.M., Reddish M.A., Zimmermann G., and Hugh J.C. The breast mucin MUCI as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer. Cancer Res. 56 (1996) 4244-4249
• Scandella E., Men Y., Gillessen S., Forster R., and Groettrup M. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 100 (2002) 1354-1361
• Thirkill T.L., Cao T., Stout M., Blankenship T.N., Barakat A., and Douglas G.C. MUC1 is involved in trophoblast transendothelial migration. Biochim. Biophys. Acta 1773 (2007) 1007-1014
• Tsutsumida H., Swanson B.J., Singh P.K., Caffrey T.C., Kitajima S., Goto M., Yonezawa S., and Hollingsworth M.A. RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells. Clin. Cancer Res. 12 (2006) 2976-2987
• Van Klinken B.J., Dekker J., Buller H.A., and Einerhand A.W. Mucin gene structure and expression: protection vs. adhesion. Am. J. Physiol. 269 (1995) G613-G627
• Wykes M., MacDonald K.P., Tran M., Quin R.J., Xing P.X., Gendler S.J., Hart D.N., and McGuckin M.A. MUC1 epithelial mucin (CD227) is expressed by activated dendritic cells. J. Leukoc. Biol. 72 (2002) 692-701
• Yanagihara S., Komura E., Nagafune J., Watarai H., and Yamaguchi Y. EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J. Immunol. 161 (1998) 3096-3102
• Yuan Z., Wong S., Borrelli A., and Chung M.A. Down-regulation of MUC1 in cancer cells inhibits cell migration by promoting E-cadherin/catenin complex formation. Biochem. Biophys. Res. Commun. 362 (2007) 740-746